Core Viewpoint - ModivCare, Inc. is facing a class action lawsuit alleging violations of the Securities Exchange Act of 1934, with claims related to misleading statements and insufficient liquidity impacting the company's financial performance [1][3]. Company Overview - ModivCare is a technology-enabled healthcare services company that offers integrated supportive care solutions for both public and private payors and their members [3]. Allegations - The lawsuit claims that ModivCare's executives made false or misleading statements and failed to disclose critical information, specifically that contract renegotiations and pricing accommodations adversely affected the company's adjusted EBITDA and that ModivCare had insufficient liquidity [3]. Legal Process - Investors who purchased ModivCare securities during the class period can seek to be appointed as lead plaintiff in the lawsuit, representing the interests of the class [4]. Law Firm Background - Robbins Geller Rudman & Dowd LLP is a leading law firm specializing in securities fraud cases, having recovered $6.6 billion for investors in such cases, significantly more than any other firm in the last four years [5].
MODV INVESTOR NOTICE: ModivCare, Inc. Investors with Substantial Losses Have Opportunity to Lead Securities Class Action Lawsuit